首页> 美国卫生研究院文献>Cancers >Loss of Tid1/DNAJA3 Co-Chaperone Promotes Progression and Recurrence of Hepatocellular Carcinoma after Surgical Resection: A Novel Model to Stratify Risk of Recurrence
【2h】

Loss of Tid1/DNAJA3 Co-Chaperone Promotes Progression and Recurrence of Hepatocellular Carcinoma after Surgical Resection: A Novel Model to Stratify Risk of Recurrence

机译:TID1 / DNAJA3的丧失促进手术切除后促进肝细胞癌的进展和复发:一种分层复发风险的新型模型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tid1 acts as a tumor suppressor in various cancer types, however, its role in hepatocellular carcinoma (HCC) remains unclear. Here, we observed a low protein level of Tid1 in poorly differentiated HCC cell lines. The expression of Tid1 affected the malignancy in human HCC cell lines; meanwhile the protein level of Nrf2 was negatively regulated by Tid1. In multivariate analysis, using immunohistochemical (IHC) assay in 210 HCC cases, we found the tumor size > 5 cm, multiple tumors, presence of vascular invasion, low Tid1 expression in the non-tumor part, and high Nrf2 expression in the non-tumor part, were independently associated with worse recurrence-free survival (RFS). A scoring system by integrating the five clinical and pathological factors predicts the RFS among HCC patients after surgical resection. In summary, Tid1 plays a prognostic role for surgically resected HCC.
机译:TID1用作各种癌症类型中的肿瘤抑制剂,然而,其在肝细胞癌(HCC)中的作用仍不清楚。在这里,我们观察到在差异差异化的HCC细胞系中的TID1的低蛋白质水平。 TID1的表达影响人HCC细胞系中的恶性肿瘤;同时,NRF2的蛋白质水平受到TID1负调节。在多变量分析中,在210例HCC病例中使用免疫组织化学(IHC)测定,我们发现肿瘤大小> 5cm,多种肿瘤,存在血管侵袭,在非肿瘤部分中的低TID1表达,并且在非肿瘤部分中的高NRF2表达。肿瘤部件,独立相关,与无复发存活率(RFS)无关。通过整合五个临床和病理因素的评分系统预测手术切除后HCC患者的RFS。总之,TID1对手术切除的HCC起着预后作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号